questionsmedicales.fr
Actions chimiques et utilisations
Actions pharmacologiques
Effets physiologiques des médicaments
Hypoglycémiants
Hypoglycémiants : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hypoglycémiants : Questions médicales les plus fréquentes",
"headline": "Hypoglycémiants : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hypoglycémiants : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-16",
"dateModified": "2025-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hypoglycémiants"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Effets physiologiques des médicaments",
"url": "https://questionsmedicales.fr/mesh/D045505",
"about": {
"@type": "MedicalCondition",
"name": "Effets physiologiques des médicaments",
"code": {
"@type": "MedicalCode",
"code": "D045505",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Inhibiteurs des glycoside hydrolases",
"alternateName": "Glycoside Hydrolase Inhibitors",
"url": "https://questionsmedicales.fr/mesh/D065089",
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteurs des glycoside hydrolases",
"code": {
"@type": "MedicalCode",
"code": "D065089",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.422.249"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Agonistes des récepteurs de l'amyline",
"alternateName": "Amylin Receptor Agonists",
"url": "https://questionsmedicales.fr/mesh/D065091",
"about": {
"@type": "MedicalCondition",
"name": "Agonistes des récepteurs de l'amyline",
"code": {
"@type": "MedicalCode",
"code": "D065091",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.422.374"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Inhibiteurs de la dipeptidyl-peptidase IV",
"alternateName": "Dipeptidyl-Peptidase IV Inhibitors",
"url": "https://questionsmedicales.fr/mesh/D054873",
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteurs de la dipeptidyl-peptidase IV",
"code": {
"@type": "MedicalCode",
"code": "D054873",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.422.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Secrétagogues à l'insuline",
"alternateName": "Insulin Secretagogues",
"url": "https://questionsmedicales.fr/mesh/D000092005",
"about": {
"@type": "MedicalCondition",
"name": "Secrétagogues à l'insuline",
"code": {
"@type": "MedicalCode",
"code": "D000092005",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.422.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Agonistes du PPAR gamma",
"alternateName": "PPAR-gamma Agonists",
"url": "https://questionsmedicales.fr/mesh/D000092126",
"about": {
"@type": "MedicalCondition",
"name": "Agonistes du PPAR gamma",
"code": {
"@type": "MedicalCode",
"code": "D000092126",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.422.688"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Inhibiteurs du cotransporteur sodium-glucose de type 2",
"alternateName": "Sodium-Glucose Transporter 2 Inhibitors",
"url": "https://questionsmedicales.fr/mesh/D000077203",
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteurs du cotransporteur sodium-glucose de type 2",
"code": {
"@type": "MedicalCode",
"code": "D000077203",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.422.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hypoglycémiants",
"alternateName": "Hypoglycemic Agents",
"code": {
"@type": "MedicalCode",
"code": "D007004",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Nunzio Cardullo",
"url": "https://questionsmedicales.fr/author/Nunzio%20Cardullo",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Giuseppe Floresta",
"url": "https://questionsmedicales.fr/author/Giuseppe%20Floresta",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Vera Muccilli",
"url": "https://questionsmedicales.fr/author/Vera%20Muccilli",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Antonio Rescifina",
"url": "https://questionsmedicales.fr/author/Antonio%20Rescifina",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Corrado Tringali",
"url": "https://questionsmedicales.fr/author/Corrado%20Tringali",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "SARS-CoV-2 rapid antigen screening of asymptomatic employees: a pilot project.",
"datePublished": "2022-09-12",
"url": "https://questionsmedicales.fr/article/36097245",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.17269/s41997-022-00691-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Health Disparities Investigator Development through a Team-Science Pilot Projects Program.",
"datePublished": "2023-03-30",
"url": "https://questionsmedicales.fr/article/37047951",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph20075336"
}
},
{
"@type": "ScholarlyArticle",
"name": "Global pen pal education intervention among student pharmacists: A pilot project.",
"datePublished": "2022-09-22",
"url": "https://questionsmedicales.fr/article/36153244",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cptl.2022.09.020"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Disposable Diaper Collection Project in Langa, Cape Town, South Africa: A Pilot Study.",
"datePublished": "2024-09-27",
"url": "https://questionsmedicales.fr/article/39457265",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph21101292"
}
},
{
"@type": "ScholarlyArticle",
"name": "Changing the Playing Field: A Prehospital Blood Product Pilot Project in Rural North Georgia.",
"datePublished": "2023-02-16",
"url": "https://questionsmedicales.fr/article/36798046",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/00031348231157833"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Actions pharmacologiques",
"item": "https://questionsmedicales.fr/mesh/D020228"
},
{
"@type": "ListItem",
"position": 4,
"name": "Effets physiologiques des médicaments",
"item": "https://questionsmedicales.fr/mesh/D045505"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hypoglycémiants",
"item": "https://questionsmedicales.fr/mesh/D007004"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hypoglycémiants - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hypoglycémiants",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hypoglycémiants",
"description": "Comment diagnostiquer une hypoglycémie ?\nQuels tests sont utilisés pour le diabète ?\nQuels symptômes indiquent une hypoglycémie ?\nQuand consulter un médecin pour hypoglycémie ?\nQuel rôle joue l'HbA1c dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Pilot+Projects&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hypoglycémiants",
"description": "Quels sont les signes d'une hypoglycémie ?\nComment reconnaître une hypoglycémie sévère ?\nLes symptômes varient-ils selon les personnes ?\nQuels symptômes nécessitent une intervention rapide ?\nLes symptômes peuvent-ils être confondus avec d'autres ?",
"url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Pilot+Projects&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hypoglycémiants",
"description": "Comment prévenir l'hypoglycémie ?\nQuel rôle joue l'exercice dans la prévention ?\nLes patients doivent-ils surveiller leur glycémie ?\nComment éduquer les patients sur l'hypoglycémie ?\nLes régimes alimentaires peuvent-ils aider ?",
"url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Pilot+Projects&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hypoglycémiants",
"description": "Quels sont les principaux hypoglycémiants ?\nComment administrer du glucose en cas d'hypoglycémie ?\nQuels sont les effets secondaires des hypoglycémiants ?\nComment ajuster le traitement hypoglycémiant ?\nLes hypoglycémiants sont-ils efficaces pour tous ?",
"url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Pilot+Projects&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hypoglycémiants",
"description": "Quelles sont les complications de l'hypoglycémie ?\nL'hypoglycémie peut-elle entraîner des séquelles ?\nComment l'hypoglycémie affecte-t-elle la qualité de vie ?\nLes complications sont-elles réversibles ?\nQuels sont les risques à long terme de l'hypoglycémie ?",
"url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Pilot+Projects&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hypoglycémiants",
"description": "Quels sont les facteurs de risque d'hypoglycémie ?\nL'âge influence-t-il le risque d'hypoglycémie ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe stress peut-il aggraver l'hypoglycémie ?\nLes médicaments peuvent-ils influencer le risque ?",
"url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Pilot+Projects&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une hypoglycémie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypoglycémie est diagnostiquée par des tests de glycémie inférieure à 70 mg/dL."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diabète ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la glycémie à jeun, l'HbA1c et le test de tolérance au glucose."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une hypoglycémie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent tremblements, sueurs, confusion et palpitations."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin pour hypoglycémie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un médecin si les symptômes persistent ou s'aggravent."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'HbA1c dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'HbA1c évalue le contrôle glycémique sur 2-3 mois, utile pour le diagnostic du diabète."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une hypoglycémie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent fatigue, irritabilité, faim intense et vertiges."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une hypoglycémie sévère ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une hypoglycémie sévère peut provoquer des convulsions, une perte de conscience ou un coma."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les personnes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier d'une personne à l'autre en fonction de la sensibilité."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent une intervention rapide ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes graves comme confusion, convulsions ou perte de conscience nécessitent une aide immédiate."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils être confondus avec d'autres ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être confondus avec ceux d'autres conditions comme l'anxiété ou l'AVC."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hypoglycémie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Prévenir l'hypoglycémie nécessite une alimentation équilibrée et un suivi régulier de la glycémie."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'exercice dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régulier aide à réguler la glycémie et à prévenir les épisodes d'hypoglycémie."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils surveiller leur glycémie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la surveillance régulière de la glycémie est essentielle pour prévenir l'hypoglycémie."
}
},
{
"@type": "Question",
"name": "Comment éduquer les patients sur l'hypoglycémie ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation doit inclure la reconnaissance des symptômes et les mesures à prendre en cas d'hypoglycémie."
}
},
{
"@type": "Question",
"name": "Les régimes alimentaires peuvent-ils aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un régime alimentaire équilibré et riche en fibres peut aider à stabiliser la glycémie."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux hypoglycémiants ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux hypoglycémiants incluent la metformine, les sulfonylurées et les inhibiteurs DPP-4."
}
},
{
"@type": "Question",
"name": "Comment administrer du glucose en cas d'hypoglycémie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le glucose peut être administré par voie orale ou intraveineuse selon la gravité."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des hypoglycémiants ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des nausées, des diarrhées et des hypoglycémies."
}
},
{
"@type": "Question",
"name": "Comment ajuster le traitement hypoglycémiant ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement doit être ajusté en fonction des niveaux de glycémie et des symptômes."
}
},
{
"@type": "Question",
"name": "Les hypoglycémiants sont-ils efficaces pour tous ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, leur efficacité peut varier selon le type de diabète et la réponse individuelle."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications de l'hypoglycémie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles neurologiques, des accidents vasculaires cérébraux et des chutes."
}
},
{
"@type": "Question",
"name": "L'hypoglycémie peut-elle entraîner des séquelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des épisodes répétés peuvent causer des dommages neurologiques permanents."
}
},
{
"@type": "Question",
"name": "Comment l'hypoglycémie affecte-t-elle la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypoglycémie fréquente peut entraîner une anxiété accrue et une diminution de la qualité de vie."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles si l'hypoglycémie est traitée rapidement."
}
},
{
"@type": "Question",
"name": "Quels sont les risques à long terme de l'hypoglycémie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques à long terme incluent des troubles cognitifs et une augmentation du risque cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'hypoglycémie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent un traitement intensif du diabète, une alimentation irrégulière et l'alcool."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'hypoglycémie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées sont plus susceptibles de souffrir d'hypoglycémie en raison de la sensibilité accrue."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de diabète peuvent augmenter le risque d'hypoglycémie."
}
},
{
"@type": "Question",
"name": "Le stress peut-il aggraver l'hypoglycémie ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affecter la glycémie et augmenter le risque d'hypoglycémie."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils influencer le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments, comme les bêta-bloquants, peuvent masquer les symptômes d'hypoglycémie."
}
}
]
}
]
}
Rapid antigen screening can be effective in identifying infectious individuals in occupational settings to reduce transmission and outbreaks. We report results from a pilot project at the Greater Toro...
An employee screening program was piloted between March 8 and May 28, 2021, to implement rapid antigen testing for asymptomatic employees. Recruitment targeted enrolment of 400 employees and yielded p...
A total of 5117 tests were performed on 717 individuals over 12 weeks; 5091 tests were negative (99.5%), and 22 individuals tested positive (3.1% positivity rate). One hundred twenty-four (17%) comple...
This pilot program identified 22 (3.1%) potentially infectious employees. Onsite testing was feasible and highly accepted by this group of employees who completed the survey. Education resulted in rea...
Profound health disparities are widespread among Native Hawaiians, other Pacific Islanders, and Filipinos in Hawai'i. Efforts to reduce and eliminate health disparities are limited by a shortage of in...
Global health, a practice that prioritizes improving health and achieving health equity for all people worldwide, is a priority for pharmacists, schools, and pharmacy colleges. Several initiatives aim...
This mixed-method study included assigned engagement within a required or elective didactic course, followed by a post-experience survey. Each student was pre-assigned a pen pal from a cohort of pharm...
In total, 184 students completed the learning experience, and across both sites, 63 students completed the post-experience survey. The students' impressions of the PPP varied by site, yet most partici...
In developing countries, there is currently no established waste management plan that includes resource recovery from used disposable diapers (DDs) apart from incineration and landfilling. In low-inco...
In Georgia, the paramedic's scope of practice prohibited the initiation of blood products. Due to the rural landscape in Georgia, one region's Regional Trauma Advisory Committee (RTAC) advocated expan...
Approval was obtained from the state medical directors and the Office of EMS and Trauma. The project team addressed product selection, equipment, prehospital service selection, education, policies and...
The pilot project began in spring of 2020, and as of January 2023, there have been 100 field initiations and no adverse effects, demonstrating the safety of paramedics to initiate blood products in th...
Future physicians are insufficiently prepared for the topic of transgender identity during their studies. Relevant courses during undergraduate medical education are heterogeneous and not widely estab...
During summer semester 2021 (SS21), the knowledge level on transgender identity of 134 medical students in their fifth clinical semester was evaluated (phase 1). In addition, knowledge gain on gender ...
The students in SS21 did not feel sufficiently educated in the topic of transgender identity through their studies, but rated the relevance of the topic for their later profession as high. Learning ga...
One 90-minutes seminar led to a significant learning gain regarding the topic of transgender identity. Community-supported teaching is a promising way to impart knowledge in a qualified manner: Medica...
To trial methods for a future longitudinal study to: a) assess how the redevelopment of a large social housing estate affects the health of tenants; and b) act on health needs identified throughout th...
Participants recruited from the tenant population completed (online or face-to-face) a health questionnaire covering self-reported health status and behaviours, housing conditions, sense of community,...
A total of 24 tenants were recruited for the pilot study against a target sample size of 50. The health questionnaire and referral process worked as expected, with no issues reported....
This pilot study successfully trialled methods for: a) assessing tenants' health; and b) referring those identified as being likely to have unmet health service needs to a community-based link worker,...
We developed a paediatric haemodialysis trigger tool (pHTT) for application per haemodialysis (HD) session in children receiving intermittent in-centre HD and systematically monitored adverse events....
Single-centre quality improvement study performed over two 8-week cycles. Data collected prospectively using a 'per-dialysis session' pHTT tool including 54 triggers across six domains, adapted from a...
There were 241 triggers over 182 dialysis sessions, with 139 triggers in 91 HD sessions for 15 children, age range 28-205 months, over an 8-week period (first cycle) and 102 triggers in 91 HD sessions...
This pilot study demonstrates potential benefits of a bedside tool to monitor adverse events during haemodialysis in children. Thus, following interventions informed by the pHTT, the harm rate per ses...
American Indian Alaska Native (AIAN) youth have disproportionately higher rates of commercial tobacco product use compared to other racial and ethnic groups in the U.S. These rates underscore a need f...
The "Virtual Semester for Medical Research Aachen" (vSEMERA) is an international, interdisciplinary, virtual education program developed for health profession students. The first edition (2021) was ho...
vSEMERA was built on a virtual learning platform, the "vSEMERA-Campus", designed to foster students' learning process and social interactions. Maximum flexibility was offered through synchronous and a...
The program received a rating of 4.38 out of 5 stars. While it met most expectations (4.29 out of 5), participants were unable to attend as many courses as intended (2.81 out of 5), mainly due to sche...
vSEMERA represents a promising example of an online international learning and exchange program using pedagogical and technological elements of virtual collaboration and teaching. In addition to advan...